Category Archives: Clinical Cardiology

The American Society of Clinical Oncology (ASCO) and its affiliate organization the Association for Clinical Oncology announced the results of a survey that addressed the changes in cancer care due to the coronavirus disease 2019 (COVID-19) pandemic.1 Specifically, the results tracked the initial impact of the COVID-19 pandemic on cancer clinical trials, highlighted a new research initiative to address the data gap on the effect of COVID-19 on individuals with cancer, and detailed possible next steps in the delivery of cancer care as systems begin to prepare for life after COVID-19. COVID-19 is placing an incredible strain on the cancer care system, causing tragic results for some patients with cancer and their families, but there has also been an unprecedented response by the oncology community, which is coming together and adapting in new ways, ASCO President Howard A. Continue reading →

Alirocumab was found to be well tolerated and to produce long-term reductions in low-density lipoprotein cholesterol (LDL-C) in patients who are intolerant to statins, according to a study published in the Journal of Clinical Lipidology. Alirocumab is an inhibitor of proprotein convertase subtilisin/kexin type 9 Continue reading →

As the coronavirus pandemic continues to rip through the US, hard-hit areas have been facing doctor shortages, placing both patients and overworked health care workers at greater risk. Thousands of foreign doctors who already have clinical experience and are waiting for a chance to practice medicine in the US could step in to help. But even before the current crisis, the immigration system, coupled with medical licensing requirements, have made it difficult for them to work in the US and go where theyre needed Continue reading →

Percutaneous left axillary artery placement of an intra-aortic balloon pump (IABP) was found to be safe and effective for patients with advanced heart failure, according to study results published in JACC: Heart Failure. In patients who require prolonged mechanical circulatory bridge support (MCS), the placement of IABP transfemorally reduces mobility and ambulation, which can lead to increased risks for infection and debilitation. The alternative axillary approach has less impact on mobility compared with the femoral strategy Continue reading →

Heart attack patients who participate in cardiac rehabilitation have a higher self-reported quality of life than those who dont. And when they add on more physical activity they feel even better, according to a new study. Investigators recruited more than 4,500 patients admitted to British hospitals with a suspected heart attack between 2011 and 2013 Continue reading →

(WZAW) -- Telehealth services provided by the U.S. Department of Veterans Affairs are increasing access to care for veterans and helping to eliminate the need for patients to travel to the nearest VA facility for a variety of appointments. For many Veterans, using telehealth services is a viable option to provide care when and where they need it most. Continue reading →

This transcript has been edited for clarity. Continue reading →

CINCINNATI--(BUSINESS WIRE)--Apr 28, 2020-- Medpace Holdings, Inc. (Nasdaq: MEDP) (Medpace) today announced financial results for the first quarter ended March 31, 2020. First Quarter 2020 Financial Results Revenue for the three months ended March 31, 2020 increased 15.0% to $230.9 million, compared to $200.7 million for the comparable prior-year period. Continue reading →

Miriam E. Tucker APRIL 28, 2020 -- An international panel of diabetes experts has published practical recommendations for managing diabetes in patients with COVID-19 both in and out of the hospital setting. The aim, they say, is to emphasize "the multiple challenges" healthcare professionals "from practitioners to intensive care staff might face in the management of .. Continue reading →

The reduction in left ventricular mass observed in patients with stable coronary artery disease and type 2 diabetes treated with empagliflozin may not result of an effect of this drug on diastolic function, according to results published in a letter to the editor in the Journal of the American Society of Echocardiography. Sodium-glucose cotransport protein 2 inhibitors such as empagliflozin have been shown to reduce heart failure hospitalization and cardiovascular death in clinical trials Continue reading →